iPierian Closes $22M Series B Financing
July 8th, 2010
No comments
iPierian, a biopharmaceutical company using patient-derived induced pluripotent stem cells (iPSCs) for drug discovery closed (7/8/10) a $22M Series B equity financing. Read more…
Categories: New Lead Investor Google Ventures, Stem Cell Technology
